Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors
Sahil Hussain, Mohd Mursal, Garima Verma, S. S. Hasan, Mohemmed Faraz Khan
Topics & Concepts
KinomeKinaseOsimertinibTyrosine kinaseImatinibCancerCancer researchReceptor tyrosine kinaseMedicineBiologyPharmacologyEpidermal growth factor receptorSignal transductionErlotinibInternal medicineCell biologyMyeloid leukemiaChronic Myeloid Leukemia TreatmentsPI3K/AKT/mTOR signaling in cancerChronic Lymphocytic Leukemia Research